Digene Corp

Digene — Q3 2007 Earnings Presentation

16 slides from Digene's earnings presentation, May 9, 2007

  1. Slide 1: Fiscal 2007 Q3 Earnings Conference Call

    Fiscal 2007 Q3 Earnings Conference Call May 8, 2007 4:30 pm EDT 1

  2. Slide 2: Forward-looking statements

    This presentation may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may vary materially from expectations. Meaningful factors which could cause actual results to differ from expectations include, but are not limited to,

  3. Slide 3: Agenda

    Agenda Daryl Faulkner - President and CEO Opening remarks Joseph Slattery - CFO FY 2007 Q3 Financial review FY 2007 Guidance update Daryl Faulkner - President and CEO FY2007 Q3 Significant Accomplishments Overview of upcoming Digene Investment Community Day Questions & Answers

  4. Slide 4: Highlights

    Highlights Total revenue up 34% to $52.5M World wide HPV test sales up 41% to $48M US HPV test sales up 43% to $41M Annualized HPV volume run rate exceeds 10M tests EU growth rate continued to trend upward in revenue and test volume GAAP EPS of $0.21/share Excluding Special Items, EPS of $0.25; 92%

  5. Slide 5: Q3FY07 Financial Highlights

    Q3FY07 Financial Highlights Joe Slattery, CFO May 8, 2007

  6. Slide 6: Third Quarter Highlights

    Third Quarter Highlights Record revenue and significant earnings performance 34% 7% Highlights Revenue up 34% YoY EU up 25% (const. curr) US up 43% EPS up 92% to $0.25/share excluding Special items $193M in Cash and Equivalents

  7. Slide 7: Global HPV Revenue

    Global HPV Revenue 41% 7% Driving the top line growth Highlights US - $40.9M - Up 43% 24% Penetration (up 2%) Stable ASP EU - $5.9M - Up 38% LA and A/P - $1.6M - Up 17%

  8. Slide 8: Geographic Growth Drivers

    Geographic Growth Drivers US United Healthcare conversion Regional labs grew 53% Continued physician education NYC/LA TV DTC campaign EU DTC Pilot in Germany Spanish guidelines published LA and A/P Continued market development China product registration Growth in all areas Globalization featured at

  9. Slide 9: Digene Financial Guidance Highlights

    ($0.24) FY01 FY02 FY03 FY04 FY05 FY06 FY07E 34.197 48.848 63.102 90.161 115.142 152.9 202 '03 -'07 CAGR: 34% $M Revenue FY01 FY02 FY03 FY04 FY05 FY06 FY07E 34.197 48.848 -0.08 0.075 0.0908 0.144 0.18 % Operating Margin Increase to $1.11/share from $1.09/share ex SI FY07Q4 - $0.30/share ex SI Increas

  10. Slide 10: Q3FY07 Significant Accomplishments

    Q3FY07 Significant Accomplishments Daryl Faulkner, President and CEO May 8, 2007

  11. Slide 11: Continued Momentum in Sales and Marketing

    Continued Momentum in Sales and Marketing US initiatives: 10 week DTC campaign in NYC and LA NY Times / People magazine / Oprah Active outreach and education for physicians EU initiatives Pilot DTC in Germany Guidelines in Spain (SEGO), Netherlands and Italy Maintain high growth trajectory in HPV fr

  12. Slide 12: Research & Development Priorities

    Dr. Jim Godsey Reorganization complete Introduced Portfolio management system Near term focus on product lifecycle upgrades Longer term focus on multi-generational product plan R&D Update: Filter plate Sample Prep Processor fastHPV test Genotyping solutions Next generation Instrumentation Set the st

  13. Slide 13: Competitive Strengths

    Competitive Strengths Proven clinical results Clinical research studies on over 100,000 women Tracking to exceed 10M women tested this year Broad health advocacy and opinion leader support Work closely with healthcare constituents Well established multi-channel sales and distribution network Consume

  14. Slide 14: Digene Investment Community Day

    Digene Investment Community Day June 5th, 2007 - New York City (NASDAQ) Agenda: Daryl Faulkner - President and CEO Doug White - SVP, S&M Jim Godsey - SVP, R&D Panel Discussion with outside speakers Chaired by Attila Lorincz Chris Meijers, University Hospital Vrije Universiteit, Amsterdam, The Nether

  15. Slide 15: E,DIGENE '

    E,DIGENE ' WF 4 ee EDIGENE * ~~

  16. Slide 16: Question and Answer Session

    Question and Answer Session Digene Participants: Daryl Faulkner - President and CEO Joe Slattery - CFO Rob Lilley - SVP, Global Sales and Marketing Doug White - SVP, S&M Americas and Asia Pacific

Digene — Q3 2007 Earnings Presentation on 6ix